CBS 2019
CBSMD教育中心
中 文

经皮左心耳封堵

Abstract

Recommended Article

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

JOURNAL: Article Link

CBS2025丨第十七届左主干暨冠状动脉分叉病变会议病例征集通知

qiaomingyue Keywords: 第十七届左主干暨冠状动脉分叉病变会议(CBS2025)将于2025年11月28日至30日在南京国际青年会议酒店举行。为促进临床工作经验的深入交流与广泛分享,本次会议特别设立了临床心血管介入治疗病例的专题交流专场。征集到的有效病例将由CBS组委会邀请的国内外心血管病专家组成的评审委员会进行统一评审。获录用的病例报告者将免除本届会议的注册费及食宿费,并将受邀在病例专场进行发言。

网站资料更新中...